Filing Details
Zenas BioPharma, Inc. (NASDAQ:ZBIO) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 13, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:ZBIO
Zenas BioPharma, Inc. (ZBIO) Files Quarterly Report for Q0
Zenas BioPharma, Inc. (NASDAQ:ZBIO) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 13, 2026.
At publication ·
What changed
Zenas BioPharma, Inc. (NASDAQ:ZBIO) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Zenas BioPharma, Inc. (NASDAQ: ZBIO) filed its quarterly report (Form 10-Q) with the SEC on August 13, 2026.
- The company's stock trades at $29.20 with a market capitalization of $1.7 billion.
- The 10-Q filing contains unaudited financial statements and management commentary on recent performance, including updated risk factors and changes in business conditions.
Market Context
Zenas BioPharma, Inc.'s stock currently trades at $29.20 with a market capitalization of $1.7B.
The 10-Q provides Zenas BioPharma, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Zenas BioPharma, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ZBIO Stock Page
Frequently Asked Questions
Where can I read ZBIO's SEC filings?
Browse all filings on our ZBIO SEC filings page.
What types of SEC filings does Zenas BioPharma, Inc. file?
Public companies like Zenas BioPharma, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.